Chester County News and Community Website
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a key milestone in its ACESOT-1051 clinical trial, as the first patient with HPV-positive (HPV+) head and neck squamous cell carcinoma (HNSCC) …
Aprea Therapeutics Advances ACESOT-1051 Clinical Trial with Key Patient Dosing Read More
BENSALEM, PA — Testlify has surpassed 30,000 recruiter sign-ups, solidifying its position as a leader in AI-driven talent assessment tools. This milestone reflects a growing shift in recruitment, as more …
Testlify Reaches 30,000 Recruiter Sign-Ups, Driving Innovation in AI-Powered Hiring Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced its financial results for the fourth quarter and fiscal year 2024, alongside key updates on its MOLBREEVI program, which aims to address …
Savara Reports 2024 Financial Results and Provides Updates on MOLBREEVI Progress Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced a strategic loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), for up to $200 million. This financing strengthens Savara’s resources …
Savara Secures $200 Million Loan Agreement with Hercules Capital Read More
LANGHORNE, PA — TEN Holdings, Inc. (Nasdaq: XHLD) has released its financial results for fiscal year 2024, marking a year focused on growth initiatives and strategic transformation.
TEN Holdings Reports 2024 Financial Results and Strategic Developments Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has announced the retirement of Werner Cautreels, PhD, from his role as Chief Executive Officer, effective March 31, 2025. This leadership transition will …
Traws Pharma Announces CEO Transition as Werner Cautreels Retires Read More
WARMINSTER, PA — Havis has unveiled the SC-2000, a premium line of adaptable self-service kiosks designed to serve the diverse needs of businesses across multiple industries. Engineered with device-agnostic compatibility and …
Havis Launches SC-2000 Self-Service Kiosks for Flexible and Customizable Solutions Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, alongside significant corporate updates. The biotechnology company reaffirmed its commitment …
Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates Read More NEWTON, PA — Traws Pharma, Inc. (NASDAQ: TRAW) is set to host a virtual investor event on Monday, March 31, 2025, at 10:00 AM ET, where the company will spotlight its …
Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19 Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting strong growth in XHANCE prescriptions and revenue. The company also …
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income Read More